FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (28)
2023
-
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795
-
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
Annals of Oncology, Vol. 34, Núm. 8, pp. 645-659
-
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile
Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674
-
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
Nature Cardiovascular Research, Vol. 2, Núm. 2, pp. 144-158
-
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
Nature Reviews Clinical Oncology, Vol. 20, Núm. 6, pp. 372-389
2022
-
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
npj Breast Cancer, Vol. 8, Núm. 1
2021
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
-
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Annals of Oncology, Vol. 32, Núm. 12, pp. 1537-1551
2019
-
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
Diabetes and Metabolism, Vol. 45, Núm. 5, pp. 409-418
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
2018
-
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database
Critical Care, Vol. 22, Núm. 1
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
-
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
Journal of the American Heart Association, Vol. 6, Núm. 7
2016
-
Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry
Journal of the American Heart Association, Vol. 5, Núm. 10
-
Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability
Cell, Vol. 166, Núm. 4, pp. 867-880
2015
-
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
New England Journal of Medicine, Vol. 373, Núm. 3, pp. 232-242
2014
-
Improving patient experience with spinal cord stimulation: Implications of position-related changes in neurostimulation
Neuromodulation, Vol. 17, Núm. SUPPL. 1, pp. 36-41
-
Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: An open-label, multicenter, single-arm, Phase II study
Journal of Infectious Diseases
2013
-
Edoxaban versus warfarin in patients with atrial fibrillation
New England Journal of Medicine, Vol. 369, Núm. 22, pp. 2093-2104
-
Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial
Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649